IAM
ABVX

Iridian Asset Management’s Abivax ABVX Stock Holding History

Iridian Asset Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
+9,165
New +$1.04M 0.42% 33

Other funds holding ABVX

NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
SCS
Syquant Capital SAS Paris, France $447M AUM 13.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Iridian Asset Management's ABVX Position: Q2 2026 in Review

Iridian Asset Management opened a new position in Abivax (ABVX) in Q2 2026: 9,165 shares worth $1.22M. The stake represents 0.42% of the portfolio and ranks #33 among its holdings.

52 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Iridian Asset Management held 9,165 shares of Abivax worth $1.22M as of Q2 2026.
  • Abivax was a new Iridian Asset Management position in Q2 2026.
  • Abivax made up 0.42% of Iridian Asset Management's portfolio in Q2 2026, its #33 holding.
  • 52 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Iridian Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.